We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
22/4/2020 11:57 | Yes this could be a life changing company in a number of ways.... As I said before I expect a stock market rally on the day the results are announced assuming they are positive... | nobbygnome | |
22/4/2020 11:55 | It'll be nice to make a bit of money from this but important not to lose sight of the fact (thank you vitec) that the primary importance is to help millions of people who suffer from respiratory related health issues similar to your son. Coronavirus if nothing else has highlighted those issues and the urgency of the global community to address them. | flashheart | |
22/4/2020 11:48 | I know my son has been hospitalised several times due to asthma and has been near death twice. I know the importance of this working. | vitec | |
22/4/2020 11:45 | Don't get me wrong I am 100% confident in SNG, I just didn't expect this to drop likeUsual bios. Granted the placing a in the hands of not normal investors was the main issue here, but the word URGENT was my ahh moment. Being an asthma sufferer myself I am all to aware of the difference a drug that prevents / improves breathing makes and I really can see this making a huge difference. Part of the issue with breathing is the panic, when you struggle you panic and panic can lead to other issues especially in the older who may have other health issues. | slinkyj | |
22/4/2020 11:38 | That is the difference between making a objective or subjective decision. Do not beat yourself up to much you are human and prone to the flaws and vunerabilities of most humans. We can all be clever after the event. It is being clever before the event that counts and then not being greedy. | vitec | |
22/4/2020 11:34 | I've watched enough bio stocks in the past to know that there is always a spike after during news then a drop. You then also get the re rise which is where we are now leading up to the next news/ results. At this stage we are too close to results and the bottom has been made since last news. I just kick myself that I didn't take my own advice and remember what happened before. I thought being an urgent study the usual wouldn't have applied . But hey ho and up we go. | slinkyj | |
22/4/2020 11:33 | The MM's want the shares they are offering me for quantity 57.3p!! | vitec | |
22/4/2020 11:16 | Because it has not gone up in a straight line for a few minutes ? The share price is trending north, now is this a bull trap or the finish of the selling we will find out over the next couple of sessions. | talk2dubya | |
22/4/2020 11:16 | A few million to be shifted I would think although the Fincap note posted on here suggested 15-20 people took the option of the placing so roughly 2-3 million shares each, I guess the question is how many are selling off. We know from after hours big trades are happening. | crookie3634 | |
22/4/2020 11:16 | I think some investors from Hemo, 4d etc will have jumped ship today to SNG. It is likely to be the most successful and 1st to market due to stage of trials etc. With that buying power coming over this ship will sail imho | slinkyj | |
22/4/2020 11:12 | Selling hasn’t finished unfortunately. Same old resistance, 58/60p. | wetdream | |
22/4/2020 11:10 | From Austria: The Austrian Federal Ministry of Social Affairs, Health, Care and Consumer Protection (BMSGPK) and other stakeholders in the health care system asked the Austrian Institute for Health Technology Assessment (AIHTA) to prepare an overview of worldwide research and development activities in the field of COVID-19, which can provide evidence-based support for future decisions. The request reached the AIHTA at the very moment it was introducing a new product line, the so-called "Policy Briefs", which are designed to provide rapid, yet evidence-based policy advice and provide a solid basis for acute decisions in health care. "We then set up a Horizon Scanning System (HSS) for the overview of COVID-19 R&D activities," explains Priv. Dr. phil. Claudia Wild, head of the AIHTA. "The aim of such an HSS is to provide early information on intervention options that are currently in the R&D stage. In the coming months, their development will be further monitored, data will be processed and purchasing by the health care system will be supported on an evidence-based foundation. Using international sources, Dr. Wild and her team has identified a total of 155 drugs that are being tested at this time for their effect against SARS-CoV-2/COVID-19. These are all based on one or more of the following known antiviral agent(s): remdesivir, lopinavir + ritonavir (Kaletra), favipirvir (Avigan), darunavir (Prezista), chloroquine phosphates (Resochin), hydroxychloroquine (Plaquenil), camostat mesilate (Foipan), APN01 (rhACE2), tocilizumab (Roactemra), sarilumab (Kevzara) and Interferon beta 1a (SNG001). | aquilla | |
22/4/2020 11:08 | ImJustDandy I don’t think we will see an RNS, any selling was placing shares and PIs. We know Lansdowne increased and Link have not been selling. The article posted on here referencing Link selling was incorrect and is being reprinted as we speak. Good to see the lead weights have been removed for now!! | crookie3634 | |
22/4/2020 11:00 | Typical I can't find the exact article on search again, but it refers to the Chinese re using a previous study called Miracle trial where it used interferon sng001 and two other drugs used for HIV. It was an article that never appeared all day until about 9pm last night as every hour I do a 1 hour search on google to see breaking news. So it was a recent article in Chinese. I can find some older references to the Miracle trial. I assume it is a re-launch for this on Covid 19 in China underway. Sorry if not much more help but I thought noteworthy enough to post. | slinkyj | |
22/4/2020 10:50 | The LAST thing we need is a recommendation by Trump! ;-) | wetdream | |
22/4/2020 10:49 | Look at those prints from 8am to 9amSeller cleared out now for sure RNS confirming soon | imjustdandy | |
22/4/2020 10:49 | Looks ready and primed for lift off after touching support. GLA with trial results. | jonnynixon | |
22/4/2020 10:44 | I'll try find it ? | slinkyj | |
22/4/2020 10:43 | Heh Slinkyj - do you have the link to that article please. Nobby might want to put in the Header | tburns | |
22/4/2020 10:35 | Big step change underway here | imjustdandy | |
22/4/2020 10:35 | I think the Chinese trials saying this is one of the 3 "Miracle trial drugs" is a strong bit of news. Google search brought it up late yesterday evening when I searched news in last hour. You have to translate it | slinkyj | |
22/4/2020 10:34 | This is just starting to get interesting! Thank you for those who gave me the chance to add in the low 50's....time to fasten those seatbelts! | likya123 | |
22/4/2020 10:34 | Won’t matter soon, any price under a quid will be a bargain. | rafboy | |
22/4/2020 10:34 | Was great to reload at 51p Happy days:)) | bmnsa | |
22/4/2020 10:30 | Most of the other covid related stocks have tanked the last few days, they have had their moment in the spotlight, now it's out turn.I expect we could see a lot jumping ship now and taking a position here which is really annoying as they are getting chance to buy in a lot cheaper than I have paid.Lol. | cambradjones |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions